|
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov. |
NIDA-CTN-0047
This was a randomized, controlled trial that enrolled 1285 participants who were identified with problematic substance use during an ED visit. Participants were randomized to one of three treatment arms: 1) minimal screening only (MSO), 2) screening, assessment, and referral to treatment (SAR), and 3) screening, assessment, and referral plus a brief intervention (BI) with two telephone follow-up booster sessions (BI-B). Follow-up assessments of all three groups were conducted at 3, 6, and 12 months post-randomization. The primary aim of the study was to compare the days of use of the patient-defined primary problem drug, assessed by the Time-Line Follow-Back, for the 30-day period preceding the 3-month follow-up between the three treatment arms. The study also evaluated a number of secondary outcome measures.
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.